Encompass Health Corp
EHCNYSE
$112.21
↓ -0.2%Jul 17 close · end-of-day
Price
1Y↑ +2.8%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$11.5B
Enterprise Value
$13.9B
P/E
20.3
P/S
1.9
P/B
4.5
EV/EBITDA
—
PEG
1.2
FCF Yield
—
Dividend Yield
0.6%
Revenue (TTM)
$5.9B
Net Income (TTM)
$566.2M
Free Cash Flow (TTM)
—
Gross Margin
—
Operating Margin
—
Net Margin
9.5%
ROE
22.4%
ROIC
—
Debt / Equity
1.0
Net Cash
-$2.5B
Return 1Y
+2.4%
Company profile
Encompass Health Corporation provides facility-based and home-based post-acute healthcare services. The company operates in two segments, Inpatient Rehabilitation, and Home Health and Hospice. As of April 11, 2022, it operated 147 hospitals, 251 home health locations, and 96 hospice locations in 42 states and Puerto Rico.
- CEO
- Mark J. Tarr
- Sector
- Services
- Industry
- Healthcare
- Employees
- 35,000
- Headquarters
- Alabama
- Website
- encompasshealth.com
Management & directors
- Coltharp Douglas EEVP & Chief Financial Officer
- Tuer Patrick WilliamEVP, Chief Operating Officer
- Fay EdmundSr. Vice Pres. and Treasurer
- Charbonneau Elissa JoyChief Medical Officer
- Darby John PatrickEVP, Gen Counsel & Secretary
- Price Andrew LChief Accounting Officer
- Tarr Mark JPresident & CEO
Roles derived from SEC Form 4 filings.
Earnings
EHC Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$1.6B↑ +9.0%
Diluted EPS$1.93↑ +30.4%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2025 |
|---|---|---|---|---|---|---|---|
| Revenue | $3.6B | $4.0B | $4.3B | $4.8B | $5.4B | — | $5.9B |
| Gross profit | — | — | — | — | — | — | — |
| Operating income | $563.9M | $559.6M | $539.5M | — | — | — | — |
| Net income | $284.2M | $412.2M | $271.0M | $352.0M | $455.7M | — | $566.2M |
| Diluted EPS | $2.85 | $4.11 | $2.70 | $3.47 | $4.46 | — | $5.54 |
| Operating cash flow | $704.7M | $715.8M | $705.8M | — | — | — | — |
| Free cash flow | $311.9M | $191.2M | $141.0M | — | — | — | — |
| Gross margin | — | — | — | — | — | — | — |
| Operating margin | 15.8% | 13.9% | 12.4% | — | — | — | — |
| Net margin | 8.0% | 10.3% | 6.2% | 7.3% | 8.5% | — | 9.5% |
| Line item | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q4 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.4B | $1.4B | $1.5B | $1.5B | — | $1.5B | $1.5B | $1.6B |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | — | — | — | — | — | — | — | — |
| Net income | $108.2M | $120.9M | $151.5M | $142.1M | — | $126.5M | $146.1M | $194.5M |
| Diluted EPS | $1.06 | $1.18 | $1.48 | $1.39 | — | $1.24 | $1.43 | $1.93 |
| Operating cash flow | — | — | — | — | — | — | — | — |
| Free cash flow | — | — | — | — | — | — | — | — |
| Gross margin | — | — | — | — | — | — | — | — |
| Operating margin | — | — | — | — | — | — | — | — |
| Net margin | 8.0% | 8.6% | 10.4% | 9.7% | — | 8.6% | 9.5% | 12.3% |
Company news
Jul 9, 2026
Jul 8, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-07-16 | Reidy Christopher R | Award | 319 | $112.40 | $35,855.60 | filing |
| 2026-07-16 | Christie Edward M III | Award | 248 | $112.43 | $27,882.64 | filing |
| 2026-07-15 | Christie Edward M III | Award | 11 | $0.00 | $0.00 | filing |
| 2026-07-15 | Williams Terrance | Award | 29 | $0.00 | $0.00 | filing |
| 2026-07-15 | SCHLICHTING NANCY M | Award | 40 | $0.00 | $0.00 | filing |
| 2026-07-15 | KATZ LESLYE G | Award | 85 | $0.00 | $0.00 | filing |
| 2026-07-15 | HERMAN JOAN E | Award | 85 | $0.00 | $0.00 | filing |
| 2026-07-15 | Hayes Cain A | Award | 4 | $0.00 | $0.00 | filing |
| 2026-07-15 | CARMICHAEL GREG D | Award | 29 | $0.00 | $0.00 | filing |
| 2026-07-15 | O'Connor Kevin J. | Award | 19 | $0.00 | $0.00 | filing |
| 2026-07-15 | Reidy Christopher R | Award | 21 | $0.00 | $0.00 | filing |
| 2026-05-15 | COLTHARP DOUGLAS E· EVP & Chief Financial Officer | Sale | 27,693 | $106.83 | $3.0M | filing |
| 2026-05-15 | COLTHARP DOUGLAS E· EVP & Chief Financial Officer | Option exercise | 27,694 | $32.94 | $912,240.36 | filing |
| 2026-05-15 | COLTHARP DOUGLAS E· EVP & Chief Financial Officer | Sale | 1 | $107.28 | $107.28 | filing |
| 2026-05-11 | Tuer Patrick William· EVP, Chief Operating Officer | Sale | 682 | $104.56 | $71,309.92 | filing |
| 2026-05-07 | O'Connor Kevin J. | Award | 1,634 | $0.00 | $0.00 | filing |
| 2026-05-07 | Christie Edward M III | Award | 1,634 | $0.00 | $0.00 | filing |
| 2026-05-07 | Reidy Christopher R | Award | 1,634 | $0.00 | $0.00 | filing |
| 2026-05-07 | Hayes Cain A | Award | 1,634 | $0.00 | $0.00 | filing |
| 2026-05-07 | CARMICHAEL GREG D | Award | 1,634 | $0.00 | $0.00 | filing |
| 2026-05-07 | KATZ LESLYE G | Award | 1,634 | $0.00 | $0.00 | filing |
| 2026-05-07 | HERMAN JOAN E | Award | 1,634 | $0.00 | $0.00 | filing |
| 2026-05-07 | SCHLICHTING NANCY M | Award | 1,634 | $0.00 | $0.00 | filing |
| 2026-05-07 | Williams Terrance | Award | 1,634 | $0.00 | $0.00 | filing |
| 2026-04-16 | Reidy Christopher R | Award | 334 | $106.48 | $35,564.32 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.